Table of Contents
What changed
Revenue slipped 4.0% to $126.2m as border restrictions continued to suppress aeronautical activity. Operating EBITDAFI fell 31.6% to $60.3m, but the income statement inverted below that line: operating profit rose 91.5% to $120.1m, PBT jumped 236.8% to $93.3m, and reported NPAT rose 287.2% to $108.8m. Management attributes the bottom-line gain to a $132m non-cash investment revaluation, and the release explicitly reconciles reported profit to an underlying loss.
Operating cash flow was broadly flat at $29.6m (HY21: $31.1m), but capex stepped up to $124.4m from $76.2m, driving pre-lease free cash flow to –$94.8m from –$45.1m. Cash on the balance sheet collapsed to $35.1m from $682.4m as the equity-raise liquidity was deployed; gross borrowings were reduced to $1,453.8m from $2,066.8m, but net debt still rose modestly to about $1,418.7m. No interim dividend was declared, matching HY21.
What matters
- Reported profit is not the operating read. PBT growth (+236.8%) diverges from NPAT growth (+287.2%) because the tax line was a benefit in both periods (effective rate –16.6% HY22, –1.4% HY21). More importantly, the $132m non-cash investment gain and the disclosed underlying loss mean the clean earnings signal is EBITDAFI down 31.6% on revenue down only 4.0% — i.e., operating deleverage worsened.
- Leverage is materially weaker despite debt paydown. Gross borrowings fell $613.0m, but with EBITDAFI annualising near $121m, net debt/EBITDAF sits around 23.5x versus 15.7x a year earlier. The balance-sheet optics improved; the coverage reality deteriorated.
- Capex is accelerating into a still-depressed revenue base. Capex of $124.4m is ~98.6% of half-year revenue, up from ~58.0% in HY21, and free cash flow before leases worsened to –$94.8m. With cash now at $35.1m, the funding mix for continued capex intensity is a live question.
Expectations
No quantified guidance or forward-work backlog was disclosed in the extracted materials. The FY21 shape is not a reliable template — HY21 represented only 46.8% of FY21 revenue but 12.4% of FY21 EBITDA and 6.1% of FY21 NPAT, because the FY21 second half included a significant fair-value uplift. Annualising HY22 revenue at $252.4m leaves the run-rate below FY21's $281.1m, so on top-line alone AIA is still tracking below the prior full year, notwithstanding the border-reopening narrative.
Quality of result
Low. The lift from PBT to NPAT is flattered by a negative effective tax rate, and the PBT lift itself is substantially attributable to a $132m non-cash investment revaluation; the company's own reconciliation points to an underlying loss. Receivable days fell to 36.6 from 64.0, which reflects lower receivables against a weak revenue base rather than a collections tailwind to cash. Operating cash flow did not keep pace with the reported profit jump — OCF/EBITDAF of 49.1% is better than HY21's 35.3% only because EBITDAF itself collapsed. The durable component of this result is the operating cost performance embedded in a 31.6% EBITDAFI decline on a 4.0% revenue decline, which is negative operating leverage, not a quality signal.
Unresolved
- The full reported-to-underlying bridge and the composition of the $132m investment gain (which asset, and whether it is likely to reverse) were not extracted.
- Net debt has edged up even though gross debt fell $613.0m; the capital plan for continued capex at ~$124m per half against $35.1m of cash is not articulated in the extracted excerpts.
- No trading update on traffic recovery, aeronautical vs. commercial mix, or FY22 capex envelope is captured here.
- Segment-level margin behaviour (aeronautical, retail, property) is not in the extraction, so the source of the EBITDAFI contraction cannot be decomposed.
This briefing cannot assess the underlying loss reconciliation, the nature of the $132m investment revaluation, or any post-period trading and border-reopening commentary, because those disclosures are not present in the supplied extraction.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $126.2m | $131.5m | -4.0% ↓ |
| Net profit after tax | $108.8m | $28.1m | +287.2% ↑ |
| Net cash inflow from operating activities | $29.6m | $31.1m | -4.8% ↓ |
| Declared dividend per share | 0.0c | 0.0c | flat |
| EBITDAF | $60.3m | $88.2m | -31.6% ↓ |
| Operating profit | $120.1m | $62.7m | +91.5% ↑ |
| Profit before tax | $93.3m | $27.7m | +236.8% ↑ |
| Cash and cash equivalents | $35.1m | $682.4m | -94.9% ↓ |
| Total assets | $9898.2m | $9197.6m | +7.6% ↑ |
Reference: annolyse.ai/briefings/aia-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | +236.8% | — | cleaner earnings measure |
| Effective tax rate | -16.6% | -1.4% | — |
| OCF / EBITDAF (cash conversion) | 49.1% | 35.3% | stable |
| FCF pre-lease | −$94.8m | −$45.1m | −$49.7m |
| FCF / NPAT | -87.1% | -160.5% | complementary conversion metric |
| Capex % revenue | 98.6% | 58.0% | — |
| Capex | −$124.4m | $76.2m | −$200.6m |
| Debtor days | 36.6 | 64.0 | -27.3 days |
| Trade debtors | $25.4m | $46.2m | −$20.8m |
| Net debt | $1418.7m | $1384.4m | +$34.3m |
| Net debt / EBITDAF | 23.50x | 15.70x | Weakening |
| Gross borrowings | $1453.8m | $2066.8m | −$613.0m |
| Payout ratio vs NPAT | 0.0% | — | — |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | 1.3% | 0.4% | Strengthening |
| HY21 share of FY21 revenue | 46.8% | — | Other half was 53.2% |
| HY21 share of FY21 EBITDAF | 12.4% | — | Other half was 87.6% |
| HY21 share of FY21 NPAT | 6.1% | — | Other half was 93.9% |
| Profit from continuing operations | $108.8m | $28.1m | +$80.7m |
Reference: annolyse.ai/briefings/aia-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.